ABL1 and interstitial lung disease: When analyzing the LFs derived from CTD‐ILD, differences in the activity of LIP‐Im and LIP‐HA44700‐Im were observed; LIP‐Im reduces the activity of cAbl by 60%, while LIP‐HA44700‐Im reduces it by 70%.